01 1Xiling Lab
01 1ERIBULIN MESYLATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-02-03
Pay. Date : 2022-12-27
DMF Number : 37629
Submission : 2022-11-30
Status : Active
Type : II
20
Xiling Lab Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is ERIBULIN MESYLATE, with a corresponding US DMF Number 37629.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 03, 2023, and payment made on December 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
